CR7429A - Composiciones de actuacion prolongada que contienen un compuesto de salicilanilida, una especie de polimero y al menos otro compuesto anti-parasiticida - Google Patents

Composiciones de actuacion prolongada que contienen un compuesto de salicilanilida, una especie de polimero y al menos otro compuesto anti-parasiticida

Info

Publication number
CR7429A
CR7429A CR7429A CR7429A CR7429A CR 7429 A CR7429 A CR 7429A CR 7429 A CR7429 A CR 7429A CR 7429 A CR7429 A CR 7429A CR 7429 A CR7429 A CR 7429A
Authority
CR
Costa Rica
Prior art keywords
compound
salicilanilide
polymer species
compositions containing
another anti
Prior art date
Application number
CR7429A
Other languages
English (en)
Inventor
Lillian Cromie
Sean Duffy
William Blakely
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of CR7429A publication Critical patent/CR7429A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Abstract

Una composicion preparada para el tratamiento de animales con parasitos, parasitos que se saben susceptibles al menos una entre avermectinas, milbemicinas o salicilanilidas, comprende por ejemplo ivermectina en una cantidad comprendida entre el 0,1 y el 10% (p/v), un solvente seleccionado dentro del grupo consistente en glicerol formal, propilenglicol, polietilenglicol y combinaciones de los mismos, y una salicilanilida tal como closantel en una dosis requerida por el animal a ser tratado, habitualmente de alrededor de 2,5 mg/kg vivo de peso del animal a ser tratado, una especie polimerica seleccionada dentro del grupo consistente en polivinilpirrolidona y copolimeros de bloque de polioxipropileno/ polioxietileno, dichas especies polimericas mejoran la biodisponibilidad del closantel en la medida que pueden lograrse niveles en plasma sanguineo de dicho compuesto de mas de alrededor de 20 ppm a lo largo de un periodo de tratamiento.
CR7429A 2002-02-28 2004-08-24 Composiciones de actuacion prolongada que contienen un compuesto de salicilanilida, una especie de polimero y al menos otro compuesto anti-parasiticida CR7429A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0204712A GB2386066A (en) 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species

Publications (1)

Publication Number Publication Date
CR7429A true CR7429A (es) 2006-02-06

Family

ID=9931978

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7429A CR7429A (es) 2002-02-28 2004-08-24 Composiciones de actuacion prolongada que contienen un compuesto de salicilanilida, una especie de polimero y al menos otro compuesto anti-parasiticida

Country Status (23)

Country Link
US (1) US9289380B2 (es)
EP (1) EP1478372B1 (es)
JP (1) JP4480400B2 (es)
AP (1) AP1977A (es)
AR (1) AR038852A1 (es)
AT (1) ATE347897T1 (es)
AU (1) AU2003205887B2 (es)
BR (1) BR0307974B1 (es)
CA (1) CA2476520C (es)
CO (1) CO5611154A2 (es)
CR (1) CR7429A (es)
CY (1) CY1107530T1 (es)
DE (1) DE60310377T2 (es)
DK (1) DK1478372T3 (es)
EC (1) ECSP045320A (es)
ES (1) ES2275076T3 (es)
GB (1) GB2386066A (es)
MX (1) MXPA04007996A (es)
NZ (1) NZ534704A (es)
PT (1) PT1478372E (es)
SI (1) SI1478372T1 (es)
WO (1) WO2003072113A1 (es)
ZA (1) ZA200406782B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
RU2005133427A (ru) 2003-03-31 2006-04-27 Алза Корпорейшн (Us) Безводные однофазные носители и препараты с использованием таких носителей
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
EP1824474A1 (en) * 2004-12-10 2007-08-29 Bayer HealthCare AG Anthelmintic composition
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
KR101200728B1 (ko) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 삼투성 전달 시스템 및 피스톤 조립체
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Fast-setting and / or cessation of substantially unchanged delivery of the product
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
FR2991173B1 (fr) 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
US10350196B2 (en) 2013-09-30 2019-07-16 Zoetis Services Llc Long-acting spiro-isoxazoline formulations
US20170258816A1 (en) 2014-09-12 2017-09-14 Antibiotx Aps Antibacterial Use of Halogenated Salicylanilides
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
MA53353A (fr) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
DE2263509C2 (de) 1972-12-27 1981-12-24 Rudolf Dr. 6380 Bad Homburg Kürner Deodorant
US4005218A (en) * 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4206205A (en) * 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
US4171314A (en) * 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
US4173571A (en) * 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
NZ197796A (en) 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
NZ210505A (en) 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
GB8727157D0 (en) * 1987-11-19 1987-12-23 Wellcome Found Pharmaceutical formulations
NZ223200A (en) * 1988-01-15 1989-01-06 Ancare Distributors Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier
US5273805A (en) * 1991-08-05 1993-12-28 Minnesota Mining And Manufacturing Company Structured flexible carrier web with recess areas bearing a layer of silicone on predetermined surfaces
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
CN1054504C (zh) 1993-03-15 2000-07-19 科尔加特·帕尔莫利弗公司 洁牙剂
PL174488B1 (pl) 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
WO1994028887A1 (en) 1993-06-15 1994-12-22 The Australian National University Synergistic anthelmintic compositions
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
AU698431B2 (en) 1993-12-13 1998-10-29 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
FR2739778B1 (fr) 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
US6340672B1 (en) 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method

Also Published As

Publication number Publication date
AP1977A (en) 2009-03-19
PT1478372E (pt) 2007-01-31
BR0307974B1 (pt) 2014-10-21
CA2476520A1 (en) 2003-09-04
US9289380B2 (en) 2016-03-22
SI1478372T1 (sl) 2007-04-30
DK1478372T3 (da) 2007-04-10
ATE347897T1 (de) 2007-01-15
EP1478372B1 (en) 2006-12-13
JP4480400B2 (ja) 2010-06-16
DE60310377D1 (de) 2007-01-25
AU2003205887A1 (en) 2003-09-09
MXPA04007996A (es) 2004-11-26
AR038852A1 (es) 2005-01-26
WO2003072113A1 (en) 2003-09-04
NZ534704A (en) 2007-02-23
CY1107530T1 (el) 2013-03-13
ZA200406782B (en) 2005-07-27
CO5611154A2 (es) 2006-02-28
EP1478372A1 (en) 2004-11-24
BR0307974A (pt) 2004-12-21
US20050118221A1 (en) 2005-06-02
ES2275076T3 (es) 2007-06-01
GB2386066A (en) 2003-09-10
GB0204712D0 (en) 2002-04-17
ECSP045320A (es) 2004-11-26
AU2003205887B2 (en) 2007-02-15
JP2005525355A (ja) 2005-08-25
DE60310377T2 (de) 2007-10-31
CA2476520C (en) 2009-08-11
AP2004003142A0 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
CR7429A (es) Composiciones de actuacion prolongada que contienen un compuesto de salicilanilida, una especie de polimero y al menos otro compuesto anti-parasiticida
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
CR7877A (es) Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor
AR044248A1 (es) Agentes para combatir parasitos en animales
BR0209057A (pt) Composições herbicidas contendo benzoilciclohexanodionas e protetores
PA8541401A1 (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
CL2008001430A1 (es) Compuestos derivados ariloazol-2-il cianoetilamino; composicion pesticida que los contiene; metodo para elaborar dichos compuestos; metodo para tratar una infeccion endoparasitaria o ectoparasitaria en un mamifero.
ECSP066360A (es) Composición parasiticida
PE20040131A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
CR7140A (es) Antranilamidas con una cadena colateral de un heteroarylsulfonil, metodos para la produccion de los mismos, su uso como medicamento o agente diagnostico y preparaciones farmaceuticas contenidas en dichos compuestos
AR057319A1 (es) Composicion para la administracion topica y metodo para evitar o tratar infeccion o infestacion endoparasitica y ectoparasitica en un animal de sangre caliente
AR060132A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas
AR038853A1 (es) Una composicion parasiticida inyectable
AR027688A1 (es) Acilsulfimidas heterociclicas, procedimiento para su preparacion, agentes que las contienen y su empleo como agentes para combatir animales perjudiciales
AR001738A1 (es) Preparados en forma de capsulas para el tratamiento de plantas y método para administrar compuestos biologicamente activos a plantas
AR052178A1 (es) Combinacion sinergica de sustancias activas herbicidas
AR013067A1 (es) Composiciones insecticidas y acaricidas y proceso para su preparacion.
AR000734A1 (es) Composicion herbicida selectiva y un proceso para el control selectivo de malezas de hoja ancha y hierbas en cultivos de plantas utiles.
AR048291A1 (es) Distribucion y preparacion mejoradas de composiciones germicidas
CL2011001775A1 (es) Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble.
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
CU23351A3 (es) Composición parasiticidal de acción retardada conteniendo un compuesto salicieanilida, una especie polimérica y al menos otro compuesto anti-parasitario
AR012832A1 (es) Composiciones insecticidas y acaricidas y proceso para su preparacion
AR022899A1 (es) Composiciones insecticidas sinergicas